VectorY
ID: 7648637VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.
4
Funding Rounds
$351.6m
Money raised
Recent Funding Rounds
Overview
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.
- Website:
- Headquarters: Amsterdam
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company VectorY has raised a total of $351.6m in funding over 4 rounds.
Key Insights:
- VectorY November 2023 Series A Funding Round: $140m
- VectorY November 2023 Series A Funding Round: $140m
- VectorY Seed round, September 2021: $37.6m
- VectorY June 2021 Seed Funding Round: $34m
Industries
VectorY is active in the following industries: